Loading…

Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function

Betatrophin is a newly identified liver-derived hormone that is associated with glucose homeostasis and lipid metabolism. Although dysregulated lipid metabolism results in diabetic nephropathy (DN) development in patients with type 2 diabetes mellitus (T2DM), it is not understood whether betatrophin...

Full description

Saved in:
Bibliographic Details
Published in:Cardiovascular diabetology 2016-01, Vol.15 (1), p.3-3, Article 3
Main Authors: Chen, Chang-Chiang, Susanto, Hendra, Chuang, Wen-Han, Liu, Ta-Yu, Wang, Chih-Hong
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c494t-b2f88751e5be1e075ce6b08d1d419773d7acee916de1e1b54d4afd164e0f84eb3
cites cdi_FETCH-LOGICAL-c494t-b2f88751e5be1e075ce6b08d1d419773d7acee916de1e1b54d4afd164e0f84eb3
container_end_page 3
container_issue 1
container_start_page 3
container_title Cardiovascular diabetology
container_volume 15
creator Chen, Chang-Chiang
Susanto, Hendra
Chuang, Wen-Han
Liu, Ta-Yu
Wang, Chih-Hong
description Betatrophin is a newly identified liver-derived hormone that is associated with glucose homeostasis and lipid metabolism. Although dysregulated lipid metabolism results in diabetic nephropathy (DN) development in patients with type 2 diabetes mellitus (T2DM), it is not understood whether betatrophin is associated with urinary albumin excretion and renal function. Based on albumin/creatinine ratio (ACR), 109 T2DM patients were divided into normoalbuminuria (ACR 300 mg/g). Serum betatrophin levels of 109 T2DM patients and 32 healthy subjects were determined by enzyme-linked immunosorbent assay (ELISA). Serum level of betatrophin was significantly increased in T2DM patients with normoalbuminuria, microalbuminuria, and macroalbuminuria as compared with healthy subjects (P < 0.001). Serum betatrophin level was positively correlated with sex, duration of diabetes, systolic blood pressure (SBP), body mass index (BMI), ACR, and triglyceride, whereas it was inversely correlated with estimated glomerular filtration rate (eGFR), total cholesterol, and high-density lipoprotein cholesterol (HDL-C) (P < 0.001). Furthermore, multivariate regression analysis showed the betatrophin was significantly and positively independent with triglyceride and low-density lipoprotein cholesterol (LDL-C) (P < 0.05), whereas it was inversely independent with eGFR, total cholesterol, and low-density lipoprotein cholesterol (HDL-C) (P < 0.05). In addition, the betatrophin had higher odds of having DN [odds ratio (OR) = 5.65, 95 % confidence interval (CI) 2.17-14.57, P < 0.001]. Betatrophin is significantly increased in T2DM patients with different stages of albuminuria. Betatrophin may be a novel endocrine regulator involved in DN development.
doi_str_mv 10.1186/s12933-015-0326-9
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4704426</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1760861697</sourcerecordid><originalsourceid>FETCH-LOGICAL-c494t-b2f88751e5be1e075ce6b08d1d419773d7acee916de1e1b54d4afd164e0f84eb3</originalsourceid><addsrcrecordid>eNpdUUtvFSEUJkZjH_oD3BgSN25GYWCA2ZiYRq1Jk27aNeFxppebGbgCU62_Xm5u29SuOOF75DvnQ-gdJZ8oVeJzof3IWEfo0BHWi258gY4pl0PXK05ePpmP0EkpW0KoVIK-Rke9kGxUTByjv-fhZgMZF8jrgi1UU3PabULEM9zCjNtQ73aAe-yDaTAUXFa7BVcLDgWbUpILpoLHv0Pd4DWHaPIdNrNdl6aFPy5DDSliEz3OEM2MpzW6_dcb9Goyc4G39-8puv7-7ersvLu4_PHz7OtF5_jIa2f7SSk5UBgsUCBycCAsUZ56TkcpmZfGAYxU-AZTO3DPzeSp4EAmxcGyU_Tl4Ltb7QLeQazZzHqXw9Ki6mSC_h-JYaNv0q3mknDei2bw8d4gp18rlKqXUBzMs4mQ1qKpFKTdVYyyUT88o27TmtvWe5ZkqsWUfWPRA8vlVEqG6TEMJXrfrD40q1uzet-sHpvm_dMtHhUPVbJ_eGmiUg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1773891672</pqid></control><display><type>article</type><title>Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><creator>Chen, Chang-Chiang ; Susanto, Hendra ; Chuang, Wen-Han ; Liu, Ta-Yu ; Wang, Chih-Hong</creator><creatorcontrib>Chen, Chang-Chiang ; Susanto, Hendra ; Chuang, Wen-Han ; Liu, Ta-Yu ; Wang, Chih-Hong</creatorcontrib><description><![CDATA[Betatrophin is a newly identified liver-derived hormone that is associated with glucose homeostasis and lipid metabolism. Although dysregulated lipid metabolism results in diabetic nephropathy (DN) development in patients with type 2 diabetes mellitus (T2DM), it is not understood whether betatrophin is associated with urinary albumin excretion and renal function. Based on albumin/creatinine ratio (ACR), 109 T2DM patients were divided into normoalbuminuria (ACR <30 mg/g), microalbuminuria (ACR between 30 and 300 mg/g), and macroalbuminuria (ACR > 300 mg/g). Serum betatrophin levels of 109 T2DM patients and 32 healthy subjects were determined by enzyme-linked immunosorbent assay (ELISA). Serum level of betatrophin was significantly increased in T2DM patients with normoalbuminuria, microalbuminuria, and macroalbuminuria as compared with healthy subjects (P < 0.001). Serum betatrophin level was positively correlated with sex, duration of diabetes, systolic blood pressure (SBP), body mass index (BMI), ACR, and triglyceride, whereas it was inversely correlated with estimated glomerular filtration rate (eGFR), total cholesterol, and high-density lipoprotein cholesterol (HDL-C) (P < 0.001). Furthermore, multivariate regression analysis showed the betatrophin was significantly and positively independent with triglyceride and low-density lipoprotein cholesterol (LDL-C) (P < 0.05), whereas it was inversely independent with eGFR, total cholesterol, and low-density lipoprotein cholesterol (HDL-C) (P < 0.05). In addition, the betatrophin had higher odds of having DN [odds ratio (OR) = 5.65, 95 % confidence interval (CI) 2.17-14.57, P < 0.001]. Betatrophin is significantly increased in T2DM patients with different stages of albuminuria. Betatrophin may be a novel endocrine regulator involved in DN development.]]></description><identifier>ISSN: 1475-2840</identifier><identifier>EISSN: 1475-2840</identifier><identifier>DOI: 10.1186/s12933-015-0326-9</identifier><identifier>PMID: 26739836</identifier><language>eng</language><publisher>England: BioMed Central</publisher><subject>Albuminuria - blood ; Albuminuria - diagnosis ; Albuminuria - etiology ; Albuminuria - physiopathology ; Angiopoietin-like Proteins ; Biomarkers - blood ; Biomarkers - urine ; Blood Pressure ; Body Mass Index ; Case-Control Studies ; Cholesterol, HDL - blood ; Cholesterol, LDL ; Diabetes Mellitus, Type 2 - blood ; Diabetes Mellitus, Type 2 - complications ; Diabetes Mellitus, Type 2 - diagnosis ; Diabetes Mellitus, Type 2 - physiopathology ; Diabetic Nephropathies - blood ; Diabetic Nephropathies - diagnosis ; Diabetic Nephropathies - etiology ; Diabetic Nephropathies - physiopathology ; Enzyme-Linked Immunosorbent Assay ; Female ; Glomerular Filtration Rate ; Humans ; Kidney - physiopathology ; Linear Models ; Male ; Middle Aged ; Multivariate Analysis ; Odds Ratio ; Original Investigation ; Peptide Hormones - blood ; Risk Factors ; Triglycerides - blood ; Up-Regulation</subject><ispartof>Cardiovascular diabetology, 2016-01, Vol.15 (1), p.3-3, Article 3</ispartof><rights>Copyright BioMed Central 2016</rights><rights>Chen et al. 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c494t-b2f88751e5be1e075ce6b08d1d419773d7acee916de1e1b54d4afd164e0f84eb3</citedby><cites>FETCH-LOGICAL-c494t-b2f88751e5be1e075ce6b08d1d419773d7acee916de1e1b54d4afd164e0f84eb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4704426/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1773891672?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26739836$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chen, Chang-Chiang</creatorcontrib><creatorcontrib>Susanto, Hendra</creatorcontrib><creatorcontrib>Chuang, Wen-Han</creatorcontrib><creatorcontrib>Liu, Ta-Yu</creatorcontrib><creatorcontrib>Wang, Chih-Hong</creatorcontrib><title>Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function</title><title>Cardiovascular diabetology</title><addtitle>Cardiovasc Diabetol</addtitle><description><![CDATA[Betatrophin is a newly identified liver-derived hormone that is associated with glucose homeostasis and lipid metabolism. Although dysregulated lipid metabolism results in diabetic nephropathy (DN) development in patients with type 2 diabetes mellitus (T2DM), it is not understood whether betatrophin is associated with urinary albumin excretion and renal function. Based on albumin/creatinine ratio (ACR), 109 T2DM patients were divided into normoalbuminuria (ACR <30 mg/g), microalbuminuria (ACR between 30 and 300 mg/g), and macroalbuminuria (ACR > 300 mg/g). Serum betatrophin levels of 109 T2DM patients and 32 healthy subjects were determined by enzyme-linked immunosorbent assay (ELISA). Serum level of betatrophin was significantly increased in T2DM patients with normoalbuminuria, microalbuminuria, and macroalbuminuria as compared with healthy subjects (P < 0.001). Serum betatrophin level was positively correlated with sex, duration of diabetes, systolic blood pressure (SBP), body mass index (BMI), ACR, and triglyceride, whereas it was inversely correlated with estimated glomerular filtration rate (eGFR), total cholesterol, and high-density lipoprotein cholesterol (HDL-C) (P < 0.001). Furthermore, multivariate regression analysis showed the betatrophin was significantly and positively independent with triglyceride and low-density lipoprotein cholesterol (LDL-C) (P < 0.05), whereas it was inversely independent with eGFR, total cholesterol, and low-density lipoprotein cholesterol (HDL-C) (P < 0.05). In addition, the betatrophin had higher odds of having DN [odds ratio (OR) = 5.65, 95 % confidence interval (CI) 2.17-14.57, P < 0.001]. Betatrophin is significantly increased in T2DM patients with different stages of albuminuria. Betatrophin may be a novel endocrine regulator involved in DN development.]]></description><subject>Albuminuria - blood</subject><subject>Albuminuria - diagnosis</subject><subject>Albuminuria - etiology</subject><subject>Albuminuria - physiopathology</subject><subject>Angiopoietin-like Proteins</subject><subject>Biomarkers - blood</subject><subject>Biomarkers - urine</subject><subject>Blood Pressure</subject><subject>Body Mass Index</subject><subject>Case-Control Studies</subject><subject>Cholesterol, HDL - blood</subject><subject>Cholesterol, LDL</subject><subject>Diabetes Mellitus, Type 2 - blood</subject><subject>Diabetes Mellitus, Type 2 - complications</subject><subject>Diabetes Mellitus, Type 2 - diagnosis</subject><subject>Diabetes Mellitus, Type 2 - physiopathology</subject><subject>Diabetic Nephropathies - blood</subject><subject>Diabetic Nephropathies - diagnosis</subject><subject>Diabetic Nephropathies - etiology</subject><subject>Diabetic Nephropathies - physiopathology</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Female</subject><subject>Glomerular Filtration Rate</subject><subject>Humans</subject><subject>Kidney - physiopathology</subject><subject>Linear Models</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Odds Ratio</subject><subject>Original Investigation</subject><subject>Peptide Hormones - blood</subject><subject>Risk Factors</subject><subject>Triglycerides - blood</subject><subject>Up-Regulation</subject><issn>1475-2840</issn><issn>1475-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdUUtvFSEUJkZjH_oD3BgSN25GYWCA2ZiYRq1Jk27aNeFxppebGbgCU62_Xm5u29SuOOF75DvnQ-gdJZ8oVeJzof3IWEfo0BHWi258gY4pl0PXK05ePpmP0EkpW0KoVIK-Rke9kGxUTByjv-fhZgMZF8jrgi1UU3PabULEM9zCjNtQ73aAe-yDaTAUXFa7BVcLDgWbUpILpoLHv0Pd4DWHaPIdNrNdl6aFPy5DDSliEz3OEM2MpzW6_dcb9Goyc4G39-8puv7-7ersvLu4_PHz7OtF5_jIa2f7SSk5UBgsUCBycCAsUZ56TkcpmZfGAYxU-AZTO3DPzeSp4EAmxcGyU_Tl4Ltb7QLeQazZzHqXw9Ki6mSC_h-JYaNv0q3mknDei2bw8d4gp18rlKqXUBzMs4mQ1qKpFKTdVYyyUT88o27TmtvWe5ZkqsWUfWPRA8vlVEqG6TEMJXrfrD40q1uzet-sHpvm_dMtHhUPVbJ_eGmiUg</recordid><startdate>20160107</startdate><enddate>20160107</enddate><creator>Chen, Chang-Chiang</creator><creator>Susanto, Hendra</creator><creator>Chuang, Wen-Han</creator><creator>Liu, Ta-Yu</creator><creator>Wang, Chih-Hong</creator><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7T5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160107</creationdate><title>Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function</title><author>Chen, Chang-Chiang ; Susanto, Hendra ; Chuang, Wen-Han ; Liu, Ta-Yu ; Wang, Chih-Hong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c494t-b2f88751e5be1e075ce6b08d1d419773d7acee916de1e1b54d4afd164e0f84eb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Albuminuria - blood</topic><topic>Albuminuria - diagnosis</topic><topic>Albuminuria - etiology</topic><topic>Albuminuria - physiopathology</topic><topic>Angiopoietin-like Proteins</topic><topic>Biomarkers - blood</topic><topic>Biomarkers - urine</topic><topic>Blood Pressure</topic><topic>Body Mass Index</topic><topic>Case-Control Studies</topic><topic>Cholesterol, HDL - blood</topic><topic>Cholesterol, LDL</topic><topic>Diabetes Mellitus, Type 2 - blood</topic><topic>Diabetes Mellitus, Type 2 - complications</topic><topic>Diabetes Mellitus, Type 2 - diagnosis</topic><topic>Diabetes Mellitus, Type 2 - physiopathology</topic><topic>Diabetic Nephropathies - blood</topic><topic>Diabetic Nephropathies - diagnosis</topic><topic>Diabetic Nephropathies - etiology</topic><topic>Diabetic Nephropathies - physiopathology</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Female</topic><topic>Glomerular Filtration Rate</topic><topic>Humans</topic><topic>Kidney - physiopathology</topic><topic>Linear Models</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Odds Ratio</topic><topic>Original Investigation</topic><topic>Peptide Hormones - blood</topic><topic>Risk Factors</topic><topic>Triglycerides - blood</topic><topic>Up-Regulation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chen, Chang-Chiang</creatorcontrib><creatorcontrib>Susanto, Hendra</creatorcontrib><creatorcontrib>Chuang, Wen-Han</creatorcontrib><creatorcontrib>Liu, Ta-Yu</creatorcontrib><creatorcontrib>Wang, Chih-Hong</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Immunology Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cardiovascular diabetology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chen, Chang-Chiang</au><au>Susanto, Hendra</au><au>Chuang, Wen-Han</au><au>Liu, Ta-Yu</au><au>Wang, Chih-Hong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function</atitle><jtitle>Cardiovascular diabetology</jtitle><addtitle>Cardiovasc Diabetol</addtitle><date>2016-01-07</date><risdate>2016</risdate><volume>15</volume><issue>1</issue><spage>3</spage><epage>3</epage><pages>3-3</pages><artnum>3</artnum><issn>1475-2840</issn><eissn>1475-2840</eissn><abstract><![CDATA[Betatrophin is a newly identified liver-derived hormone that is associated with glucose homeostasis and lipid metabolism. Although dysregulated lipid metabolism results in diabetic nephropathy (DN) development in patients with type 2 diabetes mellitus (T2DM), it is not understood whether betatrophin is associated with urinary albumin excretion and renal function. Based on albumin/creatinine ratio (ACR), 109 T2DM patients were divided into normoalbuminuria (ACR <30 mg/g), microalbuminuria (ACR between 30 and 300 mg/g), and macroalbuminuria (ACR > 300 mg/g). Serum betatrophin levels of 109 T2DM patients and 32 healthy subjects were determined by enzyme-linked immunosorbent assay (ELISA). Serum level of betatrophin was significantly increased in T2DM patients with normoalbuminuria, microalbuminuria, and macroalbuminuria as compared with healthy subjects (P < 0.001). Serum betatrophin level was positively correlated with sex, duration of diabetes, systolic blood pressure (SBP), body mass index (BMI), ACR, and triglyceride, whereas it was inversely correlated with estimated glomerular filtration rate (eGFR), total cholesterol, and high-density lipoprotein cholesterol (HDL-C) (P < 0.001). Furthermore, multivariate regression analysis showed the betatrophin was significantly and positively independent with triglyceride and low-density lipoprotein cholesterol (LDL-C) (P < 0.05), whereas it was inversely independent with eGFR, total cholesterol, and low-density lipoprotein cholesterol (HDL-C) (P < 0.05). In addition, the betatrophin had higher odds of having DN [odds ratio (OR) = 5.65, 95 % confidence interval (CI) 2.17-14.57, P < 0.001]. Betatrophin is significantly increased in T2DM patients with different stages of albuminuria. Betatrophin may be a novel endocrine regulator involved in DN development.]]></abstract><cop>England</cop><pub>BioMed Central</pub><pmid>26739836</pmid><doi>10.1186/s12933-015-0326-9</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1475-2840
ispartof Cardiovascular diabetology, 2016-01, Vol.15 (1), p.3-3, Article 3
issn 1475-2840
1475-2840
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4704426
source Open Access: PubMed Central; Publicly Available Content Database
subjects Albuminuria - blood
Albuminuria - diagnosis
Albuminuria - etiology
Albuminuria - physiopathology
Angiopoietin-like Proteins
Biomarkers - blood
Biomarkers - urine
Blood Pressure
Body Mass Index
Case-Control Studies
Cholesterol, HDL - blood
Cholesterol, LDL
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - diagnosis
Diabetes Mellitus, Type 2 - physiopathology
Diabetic Nephropathies - blood
Diabetic Nephropathies - diagnosis
Diabetic Nephropathies - etiology
Diabetic Nephropathies - physiopathology
Enzyme-Linked Immunosorbent Assay
Female
Glomerular Filtration Rate
Humans
Kidney - physiopathology
Linear Models
Male
Middle Aged
Multivariate Analysis
Odds Ratio
Original Investigation
Peptide Hormones - blood
Risk Factors
Triglycerides - blood
Up-Regulation
title Higher serum betatrophin level in type 2 diabetes subjects is associated with urinary albumin excretion and renal function
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T06%3A34%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Higher%20serum%20betatrophin%20level%20in%20type%202%20diabetes%20subjects%20is%20associated%20with%20urinary%20albumin%20excretion%20and%20renal%20function&rft.jtitle=Cardiovascular%20diabetology&rft.au=Chen,%20Chang-Chiang&rft.date=2016-01-07&rft.volume=15&rft.issue=1&rft.spage=3&rft.epage=3&rft.pages=3-3&rft.artnum=3&rft.issn=1475-2840&rft.eissn=1475-2840&rft_id=info:doi/10.1186/s12933-015-0326-9&rft_dat=%3Cproquest_pubme%3E1760861697%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c494t-b2f88751e5be1e075ce6b08d1d419773d7acee916de1e1b54d4afd164e0f84eb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1773891672&rft_id=info:pmid/26739836&rfr_iscdi=true